Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
ACTAVIS
Dec-18
ALEMBIC PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs79216,126-   
Low Rs46310,818-   
Sales per share (Unadj.) Rs287.63,955.8-  
Earnings per share (Unadj.) Rs17.4-1,274.2-  
Cash flow per share (Unadj.) Rs31.4416.9-  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.316,315.7-  
Shares outstanding (eoy) m196.56332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.23.4 64.1%   
Avg P/E ratio x36.1-10.6 -341.3%  
P/CF ratio (eoy) x20.032.3 61.8%  
Price / Book Value ratio x2.80.8 342.0%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,4024,480,758 2.8%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m11,6910-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m56,5261,315,689 4.3%  
Other income Rs m3025,160 0.1%   
Total revenues Rs m56,5571,340,849 4.2%   
Gross profit Rs m6,77234,478 19.6%  
Depreciation Rs m2,754562,428 0.5%   
Interest Rs m50275,923 0.7%   
Profit before tax Rs m3,546-578,713 -0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m126-7,334 -1.7%   
Profit after tax Rs m3,420-423,784 -0.8%  
Gross profit margin %12.02.6 457.1%  
Effective tax rate %3.61.3 280.6%   
Net profit margin %6.1-32.2 -18.8%  
BALANCE SHEET DATA
Current assets Rs m29,139539,627 5.4%   
Current liabilities Rs m16,408477,372 3.4%   
Net working cap to sales %22.54.7 476.0%  
Current ratio x1.81.1 157.1%  
Inventory Days Days1020 49.5%  
Debtors Days Days766 10.2%  
Net fixed assets Rs m31,498148,929 21.1%   
Share capital Rs m3930-   
"Free" reserves Rs m43,3120-   
Net worth Rs m43,7055,426,601 0.8%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m60,6378,483,012 0.7%  
Interest coverage x8.1-6.6 -121.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.2 601.0%   
Return on assets %6.5-4.1 -157.7%  
Return on equity %7.8-7.8 -100.2%  
Return on capital %9.3-4.8 -191.3%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Net fx Rs m19,3640-   
CASH FLOW
From Operations Rs m7,240470,046 1.5%  
From Investments Rs m-4,476258,229 -1.7%  
From Financial Activity Rs m-2,620-806,740 0.3%  
Net Cashflow Rs m144-78,073 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALEMBIC PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: CORAL LAB.  ALPA LAB  TORRENT PHARMA  BHARAT PARENTALS  GUJ.TERC LAB  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.